Sep 28, 2022 12:00 PMIRB 5

Video Conferencing/Human Research Protections Program Office of the Institutional Review Board 3600 Civic Center Blvd, 9th Floor

Oct 04, 2022 4:00 PMIRB 6

Video Conferencing/Human Research Protections Program Office of the Institutional Review Board 3600 Civic Center Blvd, 9th Floor

Oct 05, 2022 11:00 AMIRB 7

Video Conferencing/Human Research Protections Program Office of the Institutional Review Board 3600 Civic Center Blvd, 9th Floor

Oct 07, 2022 10:00 AMIRB 3

Video Conferencing/Human Research Protections Program Office of the Institutional Review Board 3600 Civic Center Blvd, 9th Floor

Oct 07, 2022 10:00 AMIRB 3

Video Conferencing/Human Research Protections Program Office of the Institutional Review Board 3600 Civic Center Blvd, 9th Floor

Oct 10, 2022 11:30 AMIRB 1

Video Conferencing/Human Research Protections Program Office of the Institutional Review Board 3600 Civic Center Blvd, 9th Floor

Oct 11, 2022 10:45 AMIRB 4

Video Conferencing/Human Research Protections Program Office of the Institutional Review Board 3600 Civic Center Blvd, 9th Floor

Oct 17, 2022 12:00 PMIRB 8

Video Conferencing/Human Research Protections Program Office of the Institutional Review Board 3600 Civic Center Blvd, 9th Floor

See future meetings »

Jun 16, 2022 5:15 PMPhysician IRB Members Needed

The Penn IRB is seeking physician scientist members to serve as IRB members. IRB members ensure the protection of the rights and welfare of participants as well as contribute to the evaluation of research on its scientific merits and standards of clinical practice. Physicians with oncology experience are greatly needed. Membership is not limited to Penn staff and faculty. Please share with anyone you may know who may be interested. Members receive onboarding training and observe meetings prior to receiving assignments. Attendance can be flexible with your schedule. Interested parties should contact the IRB Director at jessyoos@upenn.edu.

May 19, 2022 11:30 AMContinued Use of Blue Jeans with Penn Medicine Patients in Research

Over the past two years, the availability and capabilities of video conferencing tools have greatly expanded on campus, leading to redundant services with overlapping capabilities. As such, the BlueJeans Virtual Meetings service will be removed from the Common Good service portfolio next fiscal year (July 1, 2022) and will no longer be available to the majority of users after June 30, 2022. This announcement does not affect Penn Medicine’s use of BlueJeans for Telehealth nor the use of the BlueJeans Events service. Because of the change to the status of the University’s BlueJeans service, the use of BlueJeans Virtual Meetings will no longer be acceptable when hosting virtual subject visits or meetings where PHI and / or PII are discussed after June 30, 2022. The use of Penn Medicine’s Microsoft Teams or Zoom continue to be approved, provided the appropriate guidance is followed. IRB applications or research protocols that involve Penn Medicine patients and explicitly refer to Blue Jeans provided by the University should plan to submit a modification to revise the language in their applications/protocols. The IRB recommends pairing this with another planned modification. Subject consent forms may need to be revised, but existing subjects do not need to be re-consented due to this change. For questions or concerns about the change, please contact bluejeans-psomchanges@pennmedicine.upenn.edu.

Apr 14, 2022 4:00 PMRevised Common Rule Consent Changes

The IRB is announcing plans to require select research studies submitted prior to 1/21/19 to consent participants on the revised Common Rule elements.

Apr 14, 2022 3:45 PMSubmission of Penn-CHOP Reliance Agreements in HSERA

Starting July 1, 2022, requests to rely on the CHOP IRB must be submitted in HSERA and follow the IRB reliance procedures outlined on the IRB website: https://irb.upenn.edu/reliance-agreements. These requests will no longer be accepted and processed via email with the new fiscal year. Please email Patrick Stanko with any associated questions about submitting reliance agreements.

Nov 11, 2021 9:15 AM2021 Winter Holiday Break and IRB Operations

The IRB office will be closed during the Winter Holiday break (12/24/2021 - 1/4/2022). Please click to read more about impending IRB submission deadlines to ensure your submission is reviewed before the break if necessary.

Nov 04, 2021 12:00 PMPenn Medicine Guidance on Sharing Data and Biological Samples with Third Parties

Penn Medicine and Penn Audit, Compliance and Privacy have developed a new guidance on the sharing of data and biospecimens with third parties. This guidance was shared with faculty on Wednesday, November 3. It is important that the Penn Medicine research community be familiar with this guidance when submitting proposals to the IRB. The guidance is available online here: https://oacp.upenn.edu/penn-medicine-guidance-on-sharing-data-and-biolog....

Sep 20, 2021 8:45 AMNew PSOM and ACC Adverse Event Assessment Guidance

A team of seasoned clinical research professionals along with OCR Compliance and ACC DOCM collaborated to create a PSOM Guidance for Adverse Event Assessment, one that aligns with clinical workflows. The intent of the guidance is to provide early, mid and senior career investigators a roadmap for how to investigate, perform, and confirm AE assessments. The guidance will be posted on the OCR website www.med.upenn.edu/ocr/faq.html under Adverse Events.

Jul 01, 2021 11:00 AMSummer 2021 Phase III Research Resumption

As of May 21, 2021, Research Resumption has moved into Phase III. More details are online here: https://research.upenn.edu/resources/resumption/phase3. As noted in the link above, "centralized approval of research or resumption plans is not required; however, a school may elect to maintain its own policies regarding research activity." Please check with your school representatives to ensure you are compliant with local policies.

See past news »

IRB Educational Series Archive - Click here to download slides presented at various IRB training sessions

  • Minimal Risk Studies for First Time Submitters (Social/Behavioral/Educational Science) : Provides a full background for new submitters on what the IRB is & how they relate to your study, as well as tips to navigate your first SBS submission
  • Minimal Risk Studies for First Time Submitters (Biomedical Science) : Presents an introduction to IRB submissions for biomedical students & researchers, including a thorough outline of whether your project requires IRB review & tips for submitting
  • Comparative Effectiveness Trials : Outlines the landscape of considerations from the IRB when evaluating comparative effectiveness trials, including what study teams should outline in both their protocols & informed consent forms to facilitate review
  • The Common Rule : A comprehensive outline of what the Common Rule entails, including an outline of what’s changing (including broad consent, elements for consent, & ongoing requirements for continuing review) as well as how this will impact the submission of your studies
  • How to Conduct an IRB Reliance Agreement : Great for biomedical teams considering NIH funding. A complete overview of what reliance agreements are & how they work, as well as what you need to know as a submitter in order to request & obtain an agreement; also reviews expectations moving forward if relying on the Penn IRB
  • Got Data? What you need to Protect Your Research at Penn : Discussions of common concerns raised with data protection plans as well as best practices & considerations to better protect the data of your study; also includes a thorough refresher of the components & requirements outlined by HIPAA protections